Key result
Inflammatory biomarkers are associated with higher atherosclerotic burden, faster disease progression, and plaque instability in patients with advanced carotid atherosclerosis.
Why the study?
Are inflammatory biomarkers associated with plaque progression, instability, and cerebrovascular events in patients with carotid atherosclerosis?
Are inflammatory biomarkers associated with plaque progression, instability, and cerebrovascular events in patients with carotid atherosclerosis?
Inflammatory biomarkers may provide useful adjunctive criteria beyond the degree of stenosis for risk stratification in patients with carotid atherosclerosis.
No takes yet. Share an insight, caveat, or question.
May support adjunctive risk stratification beyond stenosis in carotid atherosclerosis; leaves open whether biomarkers predict events or guide therapy.
Ammirati et al. (2015) conducted a review in Carotid atherosclerosis. Inflammatory biomarkers was evaluated on Atherosclerotic burden, disease progression, and plaque instability. Inflammatory biomarkers are associated with higher atherosclerotic burden, faster disease progression, and plaque instability in patients with advanced carotid atherosclerosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: